Edition:
United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

6.75CNY
26 May 2017
Change (% chg)

¥-0.09 (-1.32%)
Prev Close
¥6.84
Open
¥6.84
Day's High
¥6.84
Day's Low
¥6.75
Volume
9,250,295
Avg. Vol
7,882,987
52-wk High
¥7.90
52-wk Low
¥6.11

600572.SS

Chart for 600572.SS

About

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills,... (more)

Overall

Beta: 0.91
Market Cap(Mil.): ¥16,947.43
Shares Outstanding(Mil.): 2,510.73
Dividend: 0.12
Yield (%): 0.99

Financials

  600572.SS Industry Sector
P/E (TTM): 35.54 14.27 17.41
EPS (TTM): 0.19 -- --
ROI: 8.24 -7.17 -5.42
ROE: 10.85 -6.63 -4.68

BRIEF-Zhejiang Conba Pharma's board elects chairman

May 10 Zhejiang Conba Pharmaceutical Co Ltd * Says board elects Hu Jiqiang as chairman Source text in Chinese: http://bit.ly/2pjt4b6 Further company coverage: (Reporting by Hong Kong newsroom)

May 10 2017

BRIEF-Zhejiang Conba Pharmaceutical to pay cash div 1.20 yuan per 10 shares for FY 2016

* Says it plans to pay cash div 1.20 yuan per 10 shares for FY 2016

Apr 20 2017

BRIEF-Zhejiang CONBA Pharmaceutical's 2016 net profit up 0.2 pct y/y

* Says 2016 net profit up 0.2 percent y/y at 441.1 million yuan ($64.07 million)

Apr 19 2017

BRIEF-Zhejiang Conba Pharmaceutical completes sale of 57.3 pct stake in pharma firm for 345.1 mln yuan

* Says co completes sale of 57.3 percent stake in pharma firm for 345.1 mln yuan

Feb 19 2017

More From Around the Web

Earnings vs. Estimates